Faslodex (fulvestrant)

Faslodex (fulvestrant) is an injectable oestrogen receptor antagonist used for the treatment of hormone receptor-positive metastatic breast cancer for postmenopausal women whose disease has progressed following treatment with prior endocrine therapy.